A study performed by Kothandapani et al. (2011) showed that the inhibition of human major AP endonuclease 1, APE1, combined with the knockdown of uracil-DNA glycosylase (UNG) and DNA polymerase β (Polβ), makes cancer cells more resistant to cisplatin. Here, POLB is linked to cancer.